Navigation Links
Developing Excellence in Alliance
Date:12/18/2007

CHAPEL HILL, N.C., Dec. 18 /PRNewswire/ -- Many large companies depend on successful strategic alliance to develop and to maintain ever-expanding product portfolio. These alliances are developed to achieve common goals and objectives; for example, large pharmaceutical companies use in-licensing deals to tap into expertise of small biotech companies and in return they offer, much needed, capital, development expertise, and market insight to the smaller companies.

While strategic alliances are an important solution to maintaining and managing a successful product portfolio, competition to secure an alliance partner is increasing. The increased competition has brought out some pertinent questions - How to maintain and manage successful strategic alliance? What factors must a company look for in strategic partner? How to keep common objectives as focus of the alliance?

Best Practices, LLC's report, Developing Excellence in Alliance, answers most important questions around successful strategic alliance. The report focuses on two objectives: 1) to identify the factors that are most important to the success of strategic alliances; and 2) to explain why those factors are considered most important.

The study evaluates the significance of 10 areas that drive success in the establishment and evolution of alliances.

-- Strategic alignment

-- Cultural fit

-- Communication

-- Due Diligence

-- Negotiation

-- Decision-making process

-- Flexibility

-- Team Coordination

-- Resources

To meet these objectives, analysts at Best Practices, LLC surveyed and interviewed seasoned executives at 12 best-in-class pharmaceutical and biotechnology companies, and harvested their top-line tactics and proven best practices in developing and managing successful alliances.

Download a summary of this report, conducted by pharmaceutical benchmarking leader Best Practices, LLC, at http://www3.best-in-class.com/rr893.htm .

Some highlights of the key findings of the report are:

1- Personal relationship development skills in business development

personnel are critical to winning alliance deals with potential partner

companies.

2- Divergent approach to risk management in product development can cause

the most tension in product development alliance deals. These issues

must be managed carefully to avoid damage to the partnership.

3- Formal alliance goals and clear decision-making processes are essential

to marinating the health of relationships and alliance progress.

To get deeper insight of the critical factors involved in developing and maintaining excellence in alliance visit http://www3.best-in-class.com/rr893.htm or contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com .

About Best Practices, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
2. Pregnancy may increase the risk of developing binge eating disorder
3. Researcher developing new method for hearing loss assessment
4. Breastfeeding does not protect children against developing asthma or allergies
5. CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans
6. amfARs MSM Initiative Seeks Proposals From Front-Line Groups Working on HIV in Developing Countries
7. Developing a modular, nanoparticle drug delivery system
8. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
9. AAAAI: Early Day Care Attendance May Protect Infants From Later Developing Asthma, From the Journal of Allergy and Clinical Immunology
10. IAEA and NFCR join forces to fight cancer in developing world
11. Engineers developing new cements to heal spinal fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree Brady ... services to communities throughout eastern Georgia, is embarking on a charity effort to ... disease kills more Americans every year than anything else, yet risk factors associated ...
(Date:1/19/2017)... ... January 19, 2017 , ... St. Catherine’s Village announced ... Siena Center is a skilled nursing facility on the grounds of the St. Catherine’s ... It recently was voted the best nursing home in Mississippi for the second year ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... Endocrinologists at Reproductive Medicine Associates of Connecticut (RMACT) have earned “Top Doctor” ... Murdock and Dr. Shaun Williams have each been chosen by their peers for ...
(Date:1/19/2017)... ... 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited to welcome ... Dr. Kim brings an extensive background in cutting-edge dermatology care and research to ... welcome back Dr. Kim to the CDG team” said President and Managing Partner Dr. ...
(Date:1/19/2017)... ... January 19, 2017 , ... "ProParagraph Basics ... simplify the editing process for all media productions," said Christina Austin - CEO ... 30 simplistically styled self-animating paragraphs designed for multi-lined text purposes. Choose from ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
Breaking Medicine Technology: